spacer
spacer

PDBsum entry 5l1h

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transport protein/inhibitor PDB id
5l1h

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
773 a.a.
Ligands
NAG ×4
GYK ×4
PDB id:
5l1h
Name: Transport protein/inhibitor
Title: Ampa subtype ionotropic glutamate receptor glua2 in complex with noncompetitive inhibitor gyki53655
Structure: Glutamate receptor 2. Chain: a, b, c, d. Fragment: unp residues 25-847, with deletions of 397-398, 402-405, 566-587. Synonym: glur-2,ampa-selective glutamate receptor 2,glur-b,glur-k2, glutamate receptor ionotropic,ampa 2,glua2. Engineered: yes
Source: Rattus norvegicus. Rat. Organism_taxid: 10116. Gene: gria2, glur2. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell_line: hek293 gnti.
Resolution:
3.80Å     R-factor:   0.277     R-free:   0.292
Authors: M.V.Yelshanskaya,A.K.Singh,J.M.Sampson,A.I.Sobolevsky
Key ref: M.V.Yelshanskaya et al. (2016). Structural Bases of Noncompetitive Inhibition of AMPA-Subtype Ionotropic Glutamate Receptors by Antiepileptic Drugs. Neuron, 91, 1305-1315. PubMed id: 27618672 DOI: 10.1016/j.neuron.2016.08.012
Date:
29-Jul-16     Release date:   19-Oct-16    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P19491  (GRIA2_RAT) -  Glutamate receptor 2 from Rattus norvegicus
Seq:
Struc:
 
Seq:
Struc:
883 a.a.
773 a.a.*
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 12 residue positions (black crosses)

 

 
DOI no: 10.1016/j.neuron.2016.08.012 Neuron 91:1305-1315 (2016)
PubMed id: 27618672  
 
 
Structural Bases of Noncompetitive Inhibition of AMPA-Subtype Ionotropic Glutamate Receptors by Antiepileptic Drugs.
M.V.Yelshanskaya, A.K.Singh, J.M.Sampson, C.Narangoda, M.Kurnikova, A.I.Sobolevsky.
 
  ABSTRACT  
 
Excitatory neurotransmission plays a key role in epileptogenesis. Correspondingly, AMPA-subtype ionotropic glutamate receptors, which mediate the majority of excitatory neurotransmission and contribute to seizure generation and spread, have emerged as promising targets for epilepsy therapy. The most potent and well-tolerated AMPA receptor inhibitors act via a noncompetitive mechanism, but many of them produce adverse side effects. The design of better drugs is hampered by the lack of a structural understanding of noncompetitive inhibition. Here, we report crystal structures of the rat AMPA-subtype GluA2 receptor in complex with three noncompetitive inhibitors. The inhibitors bind to a novel binding site, completely conserved between rat and human, at the interface between the ion channel and linkers connecting it to the ligand-binding domains. We propose that the inhibitors stabilize the AMPA receptor closed state by acting as wedges between the transmembrane segments, thereby preventing gating rearrangements that are necessary for ion channel opening.
 

 

spacer

spacer